Effects of hericium erinaceus on amyloid β(25-35) peptide-induced learning and memory deficits in mice

Biomedical Research

Volumn 32, Issue 1, 2011, Pages 67-72

  Mori, Koichiro ^a,b   Obara, Yutaro ^a   Moriya, Takahiro ^a   Inatomi, Satoshi ^b   Nakahata, Norimichi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b J   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[25-35];

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; EDIBLE MUSHROOM; FRUITING BODY; HERICIUM ERINACEUS; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; PSYCHOLOGIC TEST; RECOGNITION; SEQUENCE ANALYSIS; SHORT TERM MEMORY; SPATIAL MEMORY; THERAPY EFFECT; TREATMENT OUTCOME; VISUAL MEMORY;

AGARICALES; AMYLOID BETA-PEPTIDES; ANIMALS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED ICR; PEPTIDE FRAGMENTS; PHENOLS; RECOGNITION (PSYCHOLOGY);

BASIDIOMYCOTA; ERINACEUS; HERICIUM ERINACEUM; MUS;

EID: 79952808141     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.32.67     Document Type: Article

References (27)

1. Capsoni S, Giannotta S and Cattaneo A (2002) Nerve growth factor and galantamine ameliorate early signs of neurodegen-eration in anti-nerve growth factor mice. Proc Natl Acad Sci USA 99, 12432-12437.
2. Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19, 1-28.
3. Fischer W, Wictorin K, Bjorklund A, Williams LR, Varon S and Gage FH (1987) Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329, 65-68.
4. Giovannelli L, Casamenti F, Scali C, Bartolini L and Pepeu G (1995) Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience 66, 781-792.
5. Hardy J, Chartier-Harlin MC and Mullan M (1992) Alzheimer disease: the new agenda. Am J Hum Genet 50, 648-651.
6. Hardy J and Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
7. Huang SM, Mouri A, Kokubo H, Nakajima R, Suemoto T, Higuchi M, Staufenbiel M, Noda Y, Yamaguchi H, Nabeshima T, Saido TC and Iwata N (2006) Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neu-ronal plasticity and cognitive function. J Biol Chem 281, 17941-17951.
8. Kawagishi H, Ando M and Mizuno T (1990) Hericenone A and B as cytotoxic principles from the mushroom Hericium erinaceum. Tetrahedron Lett 31, 373-376.
9. Kawagishi H, Ando M, Sakamoto H, Yoshida S, Ojima F, Ishiguro Y, Ukai N and Furukawa S (1991) Hericenone C, D and E, stimulators of nerve growth factor (NGF) synthesis, from the mushroom Hericium erinaceum. Tetrahedron Lett 32, 4561-4564.
10. Kawagishi H, Shimada A, Hosokawa S, Mori H, Sakamoto H, Ishiguro Y, Sakemi S, Border J, Kojima N and Furukawa S (1996) Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett 37, 7399-7402.
11. Kawagishi H, Shimada A, Shirai R, Okamoto K, Ojima F, Sakamoto H, Ishiguro Y and Furukawa S (1994) Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett 35, 1569-1572.
12. Kawagishi K, Ando M, Shinba K, Sakamoto H, Yoshida S, Ojima F, Ishiguro Y, Ukai N and Furukawa S (1993) Chromans, Hericenone F, G and H from the mushroom Hericium erinaceum. Phytochemistry 32, 175-178.
13. Kromer LF (1987) Nerve growth factor treatment after brain injury prevents neuronal death. Science 235, 214-216.
14. Laursen SE and Belknap JK (1986) Intracerebroventricular injections in mice. Some methodological refnements. J Pharmacol Methods 16, 355-357.
15. Lee EW, Shizuki K, Hosokawa S, Suzuki M, Suganuma H, Inakuma T, Li J, Ohnishi-Kameyama M, Nagata T, Furukawa S and Kawagishi H (2000) Two novel diterpenoids, Erinacines H and I from the mycelia of Hericium erinaceum. Biosci Biotechnol Biochem 64, 2402-2405.
16. McDonald MP, Dahl EE, Overmier JB, Mantyh P and Cleary J (1994) Effects of an exogenous beta-amyloid peptide on retention for spatial learning. Behav Neural Biol 62, 60-67.
17. McDonald MP, Overmier JB, Bandyopadhyay S, Babcock D and Cleary J (1996) Reversal of beta-amyloid-induced retention deficit after exposure to training and state cues. Neurobiol Learn Mem 65, 35-47.
18. Mori K, Inatomi S, Ouchi K, Azumi Y and Tuchida T (2009) Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 23, 367-372.
19. Mori K, Obara Y, Hirota M, Azumi Y, Kinugasa S, Inatomi S and Nakahata N (2008) Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull 31, 1727-1732.
20. Obara Y and Nakahata N (2002) The signaling pathway of neurotrophic factor biosynthesis. Drug News Perspect 15, 290-298.
21. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG and Cotman CW (1995) Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64, 253-265.
22. Ricceri L, Alleva E, Chiarotti F and Calamandrei G (1996) Nerve growth factor affects passive avoidance learning and retention in developing mice. Brain Res Bull 39, 219-226.
23. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
24. Takei N, Tsukui H and Hatanaka H (1989) Intracellular storage and evoked release of acetylcholine from postnatal rat basal forebrain cholinergic neurons in culture with nerve growth factor. J Neurochem 53, 1405-1410.
25. Terranova JP, Kan JP, Storme JJ, Perreaut P, Le Fur G and Soubrie P (1996) Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound. Neurosci Lett 213, 79-82.
26. Tordera RM, Totterdell S, Wojcik SM, Brose N, Elizalde N, Lasheras B and Del Rio J (2007) Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci 25, 281-290.
27. Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.